(6R)-2-甲基-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]庚醛 | 3836-01-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 中文名称: (6R)-2-甲基-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-三羟基-10,13-二甲基-2,3,4,5,6,7,8,9,11,12,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基]庚醛
• 英文名称: 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al
• 英文别名: (6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal
• CAS: 3836-01-9
• 化学式: C₂₇H₄₆O₄
• 分子量: 434.7
• InChiKey: USFJGINJGUIFSY-XZULNKEGSA-N

物化性质

• 物理描述：
  Solid

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  77.8
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• METHODS AND ASSAYS FOR USE IN DIAGNOSIS OF LAMINITIS
  申请人：Pepsis Limited

  公开号：EP3773919A1

  公开（公告）日：2021-02-17
• [EN] METHODS AND ASSAYS FOR USE IN DIAGNOSIS OF LAMINITIS<br/>[FR] PROCÉDÉS ET DOSAGES POUR UTILISATION DANS LE DIAGNOSTIC DE LA FOURBURE AIGUË
  申请人：PEPSIS LTD

  公开号：WO2019186141A1

  公开（公告）日：2019-10-03

  The invention concerns a method and assay for qualifying equine laminitis disease status in a subject by measuring specific biomarkers, comparing the level of said biomarker to a control level; and correlating the measurement with laminitis disease status, wherein a statistically relevant elevated level of said biomarker is present in said sample relative to said control level.The invention further relates to immuno-based methods and assays for detecting toxins relevant to laminitis and to the use of antibodies for assay and diagnostic purposes.